Close Menu

This article has been updated to correct Thermo Fisher Scientific's stake in Yourgene Health and to provide additional information about previous loan agreements.

NEW YORK (GenomeWeb) – Thermo Fisher Scientific has acquired a 9 percent stake in molecular diagnostic company Yourgene Health by exercising warrants it held in the company.

In addition, Thermo Fisher has further warrants that, if exercised, could take its ownership to 17 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

China may include regulations protecting genes and embryos in its update of its civil code, Nature News reports.

23andMe and Airbnb have partnered to offer "heritage travel," according to Venture Beat.

In Nature this week: exome sequence analysis of individuals with type 2 diabetes, genomic prediction of maize yield across environments, and more.

NPR reports on efforts to engineer bacteriophages to destroy antibiotic-resistance bacteria.

Jun
04
Sponsored by
NanoCellect

This webinar will discuss a study that used CRISPR/Cas9 to engineer mice harboring risk variants associated with glaucoma in order to assess their functional relevance. 

Jun
06
Sponsored by
NRGene & Illumina

This webinar will discuss the impact of affordable de novo genome assemblies on crop research.

Jun
11
Sponsored by
Roche

This webinar will overview the potential for liquid biopsy approaches to monitor therapy resistance in lung cancer.

Jun
13
Sponsored by
Roche

Ribosomal ribonucleic acid (rRNA) accounts for up to 99 percent of the total RNA depending on the cell type.